69 related articles for article (PubMed ID: 2948743)
21. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
George TC; Bilsborough J; Viney JL; Norment AM
Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
[TBL] [Abstract][Full Text] [Related]
22. The helper and suppressor functions of primate T cells elicited by a 185K streptococcal antigen, as compared with the helper function elicited by a 4K streptococcal antigen.
Lehner T; Mehlert A; Avery J; Jones T; Caldwell J
J Immunol; 1985 Aug; 135(2):1437-42. PubMed ID: 3159793
[TBL] [Abstract][Full Text] [Related]
23. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
[TBL] [Abstract][Full Text] [Related]
24. Hapten-specific T cell response to azobenzenearsonate-N-acetyl-L-tyrosine in the Lewis rat. II. Induction of helper activity demonstrated by TNP-haptenated ABA-peptide-Ficoll.
Komatsu T; Amsden A; Lawn CY; Leskowitz S
J Immunol; 1983 Feb; 130(2):579-85. PubMed ID: 6336767
[TBL] [Abstract][Full Text] [Related]
25. In vitro analysis of the cellular interactions between unprimed lymphocytes responsible for determining the class of response an antigen induces: specific T cells switch a cell-mediated response to a humoral response.
Bretscher PA
J Immunol; 1983 Sep; 131(3):1103-7. PubMed ID: 6193175
[TBL] [Abstract][Full Text] [Related]
26. Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells.
Liano D; Abbas AK
J Immunol; 1987 Oct; 139(8):2562-6. PubMed ID: 2958554
[TBL] [Abstract][Full Text] [Related]
27. Chronic granulomatous disease. Expression of the metabolic defect by in vitro culture of bone marrow progenitors.
Newburger PE; Kruskall MS; Rappeport JM; Robinson SH; Chovaniec ME; Cohen HJ
J Clin Invest; 1980 Sep; 66(3):599-602. PubMed ID: 6249853
[TBL] [Abstract][Full Text] [Related]
28. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA
J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929
[TBL] [Abstract][Full Text] [Related]
29. Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells.
Krieger J; Jenis DM; Chesnut RW; Grey HM
J Immunol; 1988 Jan; 140(2):388-94. PubMed ID: 2961812
[TBL] [Abstract][Full Text] [Related]
30. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
31. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
Peterson LB; Wilner GD; Thomas DW
J Immunol; 1983 Feb; 130(2):637-43. PubMed ID: 6217245
[TBL] [Abstract][Full Text] [Related]
32. Effects of diesel exhaust particles on antigen-presenting cells and antigen-specific Th immunity in mice.
Inoue K; Koike E; Takano H; Yanagisawa R; Ichinose T; Yoshikawa T
Exp Biol Med (Maywood); 2009 Feb; 234(2):200-9. PubMed ID: 19064938
[TBL] [Abstract][Full Text] [Related]
33. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
Walden P; Nagy ZA; Klein J
J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
[TBL] [Abstract][Full Text] [Related]
34. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu DT; Katzen D; Jabara HH; Geha RS
J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
[TBL] [Abstract][Full Text] [Related]
35. Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease.
Gabrion A; Hmitou I; Moshous D; Neven B; Lefèvre-Utile A; Diana JS; Suarez F; Picard C; Blanche S; Fischer A; Cavazzana M; Touzot F
J Allergy Clin Immunol; 2017 May; 139(5):1641-1649.e6. PubMed ID: 27702670
[TBL] [Abstract][Full Text] [Related]
36. A role for NADPH oxidase in antigen presentation.
Gardiner GJ; Deffit SN; McLetchie S; Pérez L; Walline CC; Blum JS
Front Immunol; 2013 Sep; 4():295. PubMed ID: 24069023
[TBL] [Abstract][Full Text] [Related]
37. Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells.
Crotzer VL; Matute JD; Arias AA; Zhao H; Quilliam LA; Dinauer MC; Blum JS
J Immunol; 2012 Oct; 189(8):3800-4. PubMed ID: 22984083
[TBL] [Abstract][Full Text] [Related]
38. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.
Sadagopal S; Braunstein M; Hager CC; Wei J; Daniel AK; Bochan MR; Crozier I; Smith NE; Gates HO; Barnett L; Van Kaer L; Price JO; Blackwell TS; Kalams SA; Kernodle DS
PLoS One; 2009; 4(5):e5531. PubMed ID: 19436730
[TBL] [Abstract][Full Text] [Related]
39. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
